{
  "ticker": "ADN",
  "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02965023",
  "id": "02965023",
  "pages": 7,
  "price_sensitive": false,
  "date": "20250702",
  "time": "1109",
  "pdf_url": "https://announcements.asx.com.au/asxpdf/20250702/pdf/06lcsmj6dzfpdq.pdf",
  "summary": "- **Security Type**: 293,461,554 new listed options (exercise price: AUD 0.0195, expiry: 2 July 2027).  \n- **Issue Context**: Free-attaching options from a share placement (announced 12 May 2025) + 5 million options as fees to Joint Lead Managers.  \n- **Shareholder Approval**: Obtained on 30 June 2025.  \n- **Total Issued Capital Post-Quotation**:  \n  - Ordinary shares: 3,815,315,863  \n  - Options (new class): 293,461,554 (added to existing options).  \n\n*No other material information identified for trading/capital markets decisions.*",
  "usage": {
    "prompt_tokens": 2135,
    "completion_tokens": 147,
    "total_tokens": 2282,
    "prompt_tokens_details": null
  },
  "model": "deepseek/deepseek-chat-v3-0324:free",
  "processed_at": "2025-07-02T01:31:29.452309"
}